Effects of postnatal exposure to methamphetamine on the development of the rat retina

Annals of the New York Academy of Sciences

Volumn 1074, Issue , 2006, Pages 604-619

  Rodrigues, Lorena G ^a,b   Melo, Pedro ^a,c   Silva, M Carolina ^b   Tavares, Maria Amélia ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

Author keywords

Dopamine; Methamphetamine; Postnatal model; Retina development; Wistar rat

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; CATECHOLAMINE; DOPAMINE; METHAMPHETAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BODY WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL DIFFERENTIATION; NEUROCHEMISTRY; NONHUMAN; NORMAL VALUE; PERINATAL PERIOD; PROGENY; RAT; RAT STRAIN; RETINA DEVELOPMENT; SEX RATIO;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33749578299     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1369.059     Document Type: Conference Paper

References (55)

1. JOHNSTON, L.D. et al. 2004. Monitoring the future national survey results on drug use, 1975-2003. Volume I: Secondary school students (NIH Publication No. 04-5507). Bethesda, MD: National Institute on Drug Abuse.
2. JOHNSTON, L.D. et al. 2004. Monitoring the future national results on adolescent drug use: overview of key findings, 2003 (NIH Publication No. 04-5506). Bethesda, MD: National Institute on Drug Abuse.
3. VEGA, W.A. et al. 1993. Prevalence and magnitude of perinatal substance exposures in California. N. Engl. J. Med. 329: 850-854.
4. VOLKOW, N.D. et al. 2001. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry 158: 377-382.
5. MCCANN, U.D. et al. 1998. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J. Neurosci. 18: 8417-8422.
6. PLESSINGER, M.A. 1998. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet. Gynecol. Clin. North Am. 25: 119-138.
7. CERNERUD, L. et al. 1996. Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance. Acta. Paediatr. 85: 204-208.
8. ERIKSSON, M. & R. ZETTERSTROM. 1994. Amphetamine addiction during pregnancy: 10-year follow-up. Acta. Paediatr. Suppl. 404: 27-31.
9. BAKHIT, C. & J.W. GIBB. 1981. Methamphetamine-induced depression of tryptophan hydroxylase: recovery following acute treatment. Eur. J. Pharmacol. 76: 229-233.
10. HOTCHKISS, A.J. & J.W. GIBB. 1980. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214: 257-262.
11. HOTCHKISS, A.J., M.E. MORGAN & J.W. GIBB. 1979. The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci. 25: 1373-1378.
12. SEIDEN, L.S. & K.E. SABOL. 1996. Methamphetamine and methylene-dioxymethamphetamine neurotoxicity: possible mechanisms of cell destraction. NIDA Res. Monogr. 163: 251-276.
13. RODRIGUES, L.G. et al. 2004. Methamphetamine exacerbates the toxic effect of kainic acid in the adult rat retina. Neurochem. Int. 45: 1133-1141.
14. WEISSMAN, A.D. & S. CALDECOTT HAZARD. 1993. In utero methamphetamine effects: I. Behavior and monoamine uptake sites in adult offspring. Synapse 13: 241-250.
15. ACUFF-SMITH, K.D. 1993. Neurobehavioral, neurochemical, and ocular effects of prenatal methamphetamine exposure in rats as a function of dose and gestational stage. PhD, University of Cincinnati.
16. CABRERA, T.M. et al. 1993. Prenatal methamphetamine attenuates serotonin mediated renin secretion in male and female rat progeny: evidence for selective long-term dysfunction of serotonin pathways in brain. Synapse 15: 198-208.
17. SATO, M. & Y. FUJIWARA. 1986. Behavioral and neurochemical changes in pups prenatally exposed to methamphetamine. Brain Dev. 8: 390-396.
18. RICE, D. & S. BARONE, JR. 2000. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108(Suppl 3): 511-533.
19. BAYER, S.A. et al. 1993. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14: 83-144.
20. DOBBING, J. & J. SANDS. 1979. Comparative aspects of the brain growth spurt. Early Hum. Dev. 3: 79-83.
21. HENCK, J.W. 2002. Developmental neurotoxicology: testing and interpretation. In Handbook of Neurotoxicology, Vol. II. E.J. Massaro Ed.: 3-56. Humana Press. Totowa, NJ.
22. INSEL, T.R. 1995. The development ofbrain and behavior. In Psychopharmacology: the Fourth Generation of Progress. F.E. Bloom & D.J. Kupfer, Eds.: 683-694. Raven Press. New York.
23. FLETCHER, E.L. & M. KALLONIATIS. 1997. Localisation of amino acid neurotransmitters during postnatal development of the rat retina. J. Comp. Neurol. 380: 449-471.
24. WEIDMAN, T.A. & T. KUWABARA. 1968. Postnatal development of the rat retina. An electron microscopic study. Arch. Ophthalmol. 79: 470-484.
25. WEIDMAN, T.A. & T. KUWABARA. 1969. Development of the rat retina. Invest. Ophthalmol. 8: 60-69.
26. KATO, S., T. NAKAMURA & K. NEGISHI. 1980. Postnatal development of dopaminergic cells in the rat retina. J. Comp. Neurol. 191: 27-36.
27. PERRY, V.H. & M. WALKER. 1980. Morphology of cells in the ganglion cell layer during development of the rat retina. Proc. R. Soc. Lond. B. Biol. Sci. 208: 433-445.
28. ALI, S.F. et al. 1994. MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels. Synapse 18: 27-34.
29. WOLFENSOHN, S. & M. LLOYD. 1998. Handbook of Laboratory Animal Management and Welfare. Blackwell Science. Oxford.
30. GOMES-DA-SILVA, J. 2002. Efeito da metanfetamina na ontogenia das vias dopaminérgicas do sistema nervoso do rato. PhD, University of Porto, Porto.
31. SILVA-ARAUJO, A. et al. 1995. Effects of prenatal cocaine exposure in the retinal ganglion cell layer of the rat. A morphometric analysis. Mol. Neurobiol. 11: 87-97.
32. SILVA-ARAUJO, A. et al. 1996. The effects of prenatal exposure to cocaine on the dopaminergic cells in the rat retina. An immunocytochemical and neurochemical study. Exp. Eye Res. 62: 697-708.
33. SILVA-ARAUJO, A. & M.A. TAVARES. 1996. Development of the eye after gestational exposure to cocaine. Vascular disruption in the retina of rats and humans. Ann. N. Y. Acad. Sci. 801: 274-288.
34. TAVARES, M.A. & M.C. SILVA. 1993. Body weight gain and hippocampal volumes of rats exposed neonatally to psychostimulants. Brain Res. 619: 137-145.
35. MELO, P. et al. 2005. Methamphetamine and lipid peroxidation in the rat retina. Birth Defects Res. A Clin. Mol. Teratol. 73: 455-460.
36. DIXON, S.D. & R. BEJAR. 1989. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J. Pediatr. 115: 770-778.
37. ORO, A.S. & S.D. DIXON. 1987. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J. Pediatr. 111: 571-578.
38. SMITH, L. et al. 2003. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J. Dev. Behav. Pediatr. 24: 17-23.
39. ACUFF-SMITH, K.D. et al. 1996. Stage-specific effects of prenatal d-methamphetamine exposure on behavioral and eye development in rats. Neurotoxicol. Teratol. 18: 199-215.
40. CHO, D.H. et al. 1991. Behavioral teratogenicity of methamphetamine. J. Toxicol. Sci. 16(Suppl 1): 37-49.
41. TAVARBS, M.A. & M.C. SILVA. 1996. Differential effects of prenatal exposure to cocaine and amphetamine on growth parameters and morphometry of the prefrontal cortex in the rat. Ann. N. Y. Acad. Sci. 801: 256-273.
42. TAVARES, M.A. et al. 1996. Effects of prenatal exposure to amphetamine in the medial prefrontal cortex of the rat. Int. J. Dev. Neurosci. 14: 585-596.
43. WILLIAMS, M.T., M.S. MORAN & C.V. VORHEES. 2003. Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze. Psychopharmacology (Berl.) 168: 329-338.
44. WILLIAMS, M.T. et al. 2003. Developmental D-methamphetamine treatment selectively induces spatial navigation impairments in reference memory in the Morris water maze while sparing working memory. Synapse 48: 138-148.
45. CAPPON, G.D., L.L. MORFORD & C.V. VORHEES. 1997. Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response. Brain Res. Dev. Brain Res. 103: 155-162.
46. FARFEL, G.M. & L.S. SEIDEN. 1995. Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. J. Pharmacol. Exp. Ther. 272: 868-875.
47. CONKLIN, P. & F.W. HEGGENESS. 1971. Maturation of temperature homeostasis in the rat. Am. J. Physiol. 220: 333-336.
48. DJAMGOZ, M.B. et al. 1997. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res. 37: 3509-3529.
49. NGUYEN LEGROS, J. et al. 1981. Tyrosine hydroxylase-like immunoreactive interplexiform cells in the rat retina. Neurosci. Lett. 27: 255-259.
50. VERSAUX-BOTTERI, C. et al. 1986. Regional specialization of the rat retina: catecholamine-containing amacrine cell characterization and distribution. J. Comp. Neurol. 243: 422-433.
51. WITKOVSKY, P. & M. SCHUTTE. 1991. The organization of dopaminergic neurons in vertebrate retinas. Vis. Neurosci. 7: 113-124.
52. VARELLA, M.H., EG. DE MELLO & R. LINDEN. 1999. Evidence for an antiapoptotic role of dopamine in developing retinal tissue. J. Neurochem. 73: 485-492.
53. KASHII, S. et al. 1994. Protective action of dopamine against glutamate neurotoxicity in the retina. Invest. Ophthalmol. Vis. Sci. 35: 685-695.
54. LANKFORD, K.L., F.G. DEMELLO & W.L. KLEIN. 1988. D1-type dopamine receptors inhibit growth cone motility in cultured retina neurons: evidence that neurotransmitters act as morphogenic growth regulators in the developing central nervous system. Proc. Natl. Acad. Sci. USA. 85: 4567-4571.
55. CAO, W. et al. 1993. Effects of experimentally induced ischemia on dopamine metabolism in rabbit retina. Invest. Ophthalmol. Vis. Sci. 34: 3140-3146.